Medigen touts deal with CDC over 5m COVID-19 vaccinesBy Chen Cheng-hui / Staff reporterThe Centers for Disease Control (CDC) is to purchase 5 million doses of an experimental COVID-19 vaccine by Medigen Vaccine Biologics Corp (高端疫苗), the Hsinchu-based firm said in a regulatory filing yesterday. The procurement agreement also includes a subsequent purchase of up to 5 million more doses, Medigen said. The company did not disclose further details, citing terms agreed with the CDC. A Medigen Vaccine Biologics Corp worker handles the company’s experimental COVID-19 vaccine at a laboratory in the Hsinchu Biomedical Science Park on Aug. 30 last year. Photo: CNAThe delivery of the drug, pending approval, would have a positive effect on the firm’s finances and operations, it said.

Source: Taipei Times May 30, 2021 15:56 UTC